<DOC>
	<DOCNO>NCT01832038</DOCNO>
	<brief_summary>The purpose trial evaluate safety tolerability long-term administration Lacosamide dose 400 mg/day Japanese Chinese adult Epilepsy complete Treatment Transition Period EP0008 [ NCT01710657 ]</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability , Efficacy Long-term Adjunctive Therapy With Lacosamide Adults With Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject complete Treatment Transition Period EP0008 [ NCT01710657 ] Subjects withdraw EP0008 [ NCT01710657 ]</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial-onset Seizures</keyword>
</DOC>